Evidence map›Paper›PMID 40140128›Full record

ArticlePharmaceutical research2025

GraphDeep-hERG: Graph Neural Network PharmacoAnalytics for Assessing hERG-Related Cardiotoxicity.

Yankang Jing, Yiyang Zhang, Guangyi Zhao, Terence McGuire, Jack Zhao, Ben Gibbs, Ganqian Hou, Zhiwei Feng, Ying Xue, Xiang-Qun Xie

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yankang JingDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Yiyang ZhangDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Guangyi ZhaoDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Terence McGuireDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Jack ZhaoDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Ben GibbsDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Ganqian HouDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Zhiwei FengDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA. ZHF11@pitt.edu.
Ying XueDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA. yix49@pitt.edu.
Xiang-Qun XieDepartment of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, 6411 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA. xix15@pitt.edu.ORCID http://orcid.org/0000-0002-6881-6175

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe human Ether-a-go-go Related-Gene (hERG) encodes rectifying potassium channels that play a significant role during action potential repolarization of cardiomyocytes. Blockade of the hERG channel by off-target drugs can lead to long QT syndrome, significantly increasing the risk of proarrhythmic cardiotoxicity. Traditional hERG screening methods are effort-demanding and time-consuming. Thus, it is essential to develop computational methods to utilize the existing knowledge for faster and more accurate in silico screening. Although with wide use of deep learning/machine learning algorithms, existing computational models often rely on manually defined atomic features to represent atom nodes, which may overlook critical underlying information. Thus, we want to provide a new method to learn the atom representation automatically.

methodsWe first developed an automated atom embedding model using deep neural networks (DNNs), trained with 118,312 compounds collected from the ZINC database. We then trained a Graph neural networks (GNNs) model with 7909 ChEMBL compounds as the classifying part. The integration of our atom embedding model and GNN models formed a classifier that could effectively distinguish between hERG inhibitors and non-inhibitors.

resultsOur atom embedding model achieved 0.93 accuracy in representing structures. Our best GNN model achieved an accuracy of 0.84 and outcompeted traditional machine-learning models, as well as published AI-driven models, in external testing.

conclusionsThese results highlight the potential of our automated atom embedding model as a standard for generating robust molecular representations. Its integration with advanced GNN algorithms offers promising assistance for screening hERG inhibitors and accelerating drug discovery and repurposing.

Indexed as

CardiotoxicityERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsNeural Networks, ComputerPotassium Channel BlockersAction PotentialsAlgorithmsComputer SimulationDeep LearningGraph Neural NetworksHumansMachine LearningERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsKCNH2 protein, humanPotassium Channel Blockersalzheimer’s diseaseatom-type embedding modelcardiovascular toxicitydeep learning/machine learninggraph neural networksHERG

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.